p-aminoazobenzene has been researched along with quinacrine in 1 studies
*Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2. [MeSH]
*Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doh-ura, K; Karube, Y; Kataoka, Y; Naito, M; Tamura, K; Tsuruo, T | 1 |
1 other study(ies) available for p-aminoazobenzene and quinacrine
| Article | Year |
|---|---|
Chelating compound, chrysoidine, is more effective in both antiprion activity and brain endothelial permeability than quinacrine.
Topics: Animals; Brain; Cell Membrane Permeability; Chelating Agents; Drug Evaluation, Preclinical; Endothelial Cells; Mice; Models, Biological; p-Aminoazobenzene; Prion Diseases; Prions; Protein Binding; PrPSc Proteins; Quinacrine; Recombinant Proteins; Tumor Cells, Cultured | 2007 |